The class of compounds known as GGA1 inhibitors pertains to a group of chemical agents that have been extensively investigated for their ability to modulate cellular processes involving the Golgi-localized γ-adaptin ear domain homology ARF-binding protein 1 (GGA1). GGA1 is an integral component of the endocytic and lysosomal trafficking machinery, playing a crucial role in the sorting and transport of cargo proteins between the trans-Golgi network (TGN) and endosomes. GGA1 inhibitors are characterized by their capacity to interfere with the interactions between GGA1 and cargo proteins, ubiquitin, and other associated components, thereby altering the normal trajectory of cargo transport and influencing cellular sorting mechanisms. The mechanisms of action of GGA1 inhibitors are diverse and multifaceted, reflecting their varied chemical structures and modes of interaction with the cellular machinery. Some inhibitors disrupt GGA1's interaction with cargo proteins, preventing their effective sorting and transport to lysosomes.
This disruption can lead to the mislocalization or altered processing of cargo, impacting cellular homeostasis. Additionally, certain GGA1 inhibitors hinder GGA1's binding to ubiquitin, a key post-translational modification that regulates cargo selection. By interfering with this interaction, these inhibitors contribute to the perturbation of cargo trafficking pathways and affect cargo degradation dynamics. The development and study of GGA1 inhibitors have provided valuable insights into the complex intricacies of intracellular trafficking pathways and the pivotal role that GGA1 plays in these processes. While GGA1 inhibitors hold potential for influencing cellular sorting mechanisms, their precise effects can be influenced by factors such as inhibitor specificity, concentration, and cellular context. Continued research into the detailed mechanisms by which GGA1 inhibitors operate is essential to comprehensively understand their impact on intracellular trafficking and cargo processing, potentially uncovering new avenues for modulating cellular pathways and advancing our fundamental knowledge of cellular biology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts GGA1-mediated transport by inhibiting ADP-ribosylation factor (ARF) activation, causing Golgi apparatus disassembly and impaired protein trafficking. | ||||||
Rottlerin | 82-08-6 | sc-3550 sc-3550B sc-3550A sc-3550C sc-3550D sc-3550E | 10 mg 25 mg 50 mg 1 g 5 g 20 g | $84.00 $166.00 $302.00 $2091.00 $5212.00 $16657.00 | 51 | |
Downregulates GGA1 expression, leading to reduced GGA1-mediated cargo sorting and trafficking. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Interferes with GGA1 interaction with cargo proteins, disrupting sorting and transport processes from the trans-Golgi network to lysosomes. | ||||||
Curvularin | 10140-70-2 | sc-202113 sc-202113A | 1 mg 5 mg | $64.00 $256.00 | ||
Inhibits GGA1-mediated cargo sorting by disrupting the interaction between GGA1 and cargo proteins. | ||||||
Sodium Salicylate | 54-21-7 | sc-3520 sc-3520A sc-3520B sc-3520C | 1 g 25 g 500 g 1 kg | $10.00 $26.00 $82.00 $139.00 | 8 | |
Disrupts GGA1-mediated cargo trafficking by interfering with the ubiquitination and sorting of cargo proteins. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Affects GGA1-mediated sorting by inhibiting tyrosine kinase activity, leading to altered cargo trafficking and degradation pathways. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Alters GGA1-mediated cargo trafficking by raising endosomal pH, affecting cargo sorting and eventual lysosomal degradation. | ||||||